Hainan Boao Research Hospital, operated by Shanghai’s Ruijin Hospital, has obtained provincial approval to import China’s first medical-food product for children with methylmalonic acidemia (MMA) or propionic acidemia (PA). This achievement marks the second regulatory clearance for the Boao Lecheng pilot zone this year.
Medical-Food Product Details
The temporary import license covers Vidolife MMA/PA explore5, a medical food designed specifically for children aged one to five years. This product is formulated to reduce the accumulation of toxic metabolites and meet the specific protein requirements of MMA/PA patients. The powder is methionine-, threonine-, and valine-free and contains low isoleucine along with a balanced profile of amino acids, carbohydrates, fats, vitamins, minerals, trace elements, ARA, and DHA.-Fineline Info & Tech
